BOTHELL, Wash. (AP) _ Alder BioPharmaceuticals Inc. (ALDR) on Monday reported a loss of $60.9 million in its third quarter.

On a per-share basis, the Bothell, Washington-based company said it had a loss of 91 cents.

The results surpassed Wall Street expectations. The average estimate of five analysts surveyed by Zacks Investment Research was for a loss of $1.13 per share.

Alder BioPharmaceuticals shares have climbed 24 percent since the beginning of the year. In the final minutes of trading on Monday, shares hit $14.25, a climb of 30 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ALDR at https://www.zacks.com/ap/ALDR

Recommended for you

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.